Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 625824, 8 pages
http://dx.doi.org/10.1155/2013/625824
Research Article

Medium-Chain Acyl-CoA Deficiency: Outlines from Newborn Screening, In Silico Predictions, and Molecular Studies

1Department of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Viale Pieraccini 24, 50139 Florence, Italy
2Molecular and Cell Biology Laboratory, Paediatric Neurology Unit and Laboratories, Neuroscience Department, A. Meyer Children’s Hospital, Viale Pieraccini 24, 50139 Florence, Italy
3Buck Institute for Research on Aging, 8001 Redwood Blvd., Novato, CA 94945, USA
4Newborn Screening Biochemistry and Pharmacology Laboratory, Clinic of Paediatric Neurology, A. Meyer Children’s Hospital, Viale Pieraccini 24, 50139 Florence, Italy
5Metabolic Disorders Unit, Neuroscience Department, A. Meyer Children’s Hospital, Viale Pieraccini 24, 50139 Florence, Italy
6Department of Pediatrics, University of Bologna, Via Massarenti 13, 40138 Bologna, Italy
7Pediatric Neurology Unit and Laboratories, Neuroscience Department, A. Meyer Children’s Hospital, Viale Pieraccini 24, 50139 Florence, Italy

Received 19 August 2013; Accepted 12 September 2013

Academic Editors: G. Briassoulis and R. Gorodischer

Copyright © 2013 Serena Catarzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Ikeda, K. Okamura-Ikeda, and K. Tanaka, “Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme,” Journal of Biological Chemistry, vol. 260, no. 2, pp. 1311–1325, 1985. View at Google Scholar · View at Scopus
  2. C. Lovera, F. Porta, A. Caciotti et al., “Sudden unexpected infant death (SUDI) in a newborn due to medium chain acyl CoA dehydrogenase (MCAD) deficiency with an unusual severe genotype,” The Italian Journal of Pediatrics, vol. 38, article 59, 2012. View at Publisher · View at Google Scholar
  3. C. Roe and J. Ding, “Mitochondrial fatty acid oxidation disorders,” in The Metabolic and Molecular Bases of Inherited Disease, C. Scriver, A. Beaudet, W. Sly, and D. Valle, Eds., vol. 312, pp. 2297–2325, McGraw Hill, New York, NY, USA, 8th edition, 2001. View at Google Scholar
  4. R. Yusupov, D. N. Finegold, E. W. Naylor, I. Sahai, S. Waisbren, and H. L. Levy, “Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening,” Molecular Genetics and Metabolism, vol. 101, no. 1, pp. 33–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Grosse, M. J. Khoury, C. L. Greene, K. S. Crider, and R. J. Pollitt, “The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update,” Genetics in Medicine, vol. 8, no. 4, pp. 205–212, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Nennstiel-Ratzel, S. Arenz, E. M. Maier et al., “Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening,” Molecular Genetics and Metabolism, vol. 85, no. 2, pp. 157–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Waddell, V. Wiley, K. Carpenter et al., “Medium-chain acyl-CoA dehydrogenase deficiency: genotype-biochemical phenotype correlations,” Molecular Genetics and Metabolism, vol. 87, no. 1, pp. 32–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. F. Zhang, D. P. Kelly, J. J. Kim et al., “Structural organization and regulatory regions of the human medium-chain acyl-CoA dehydrogenase gene,” Biochemistry, vol. 31, no. 1, pp. 81–89, 1992. View at Google Scholar · View at Scopus
  9. Y. Ikeda, S. M. Keese, W. A. Fenton, and K. Tanaka, “Biosynthesis of four rat liver mitochondrial acyl-CoA dehydrogenases: in vitro synthesis, import into mitochondria, and processing of their precursors in a cell-free system and in cultured cells,” Archives of Biochemistry and Biophysics, vol. 252, no. 2, pp. 662–674, 1987. View at Google Scholar · View at Scopus
  10. D. P. Kelly, J. J. Kim, J. J. Billadello, B. E. Hainline, T. W. Chu, and A. W. Strauss, “Nucleotide sequence of medium-chain acyl-CoA dehydrogenase mRNA and its expression in enzyme-deficient human tissue,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 12, pp. 4068–4072, 1987. View at Google Scholar · View at Scopus
  11. Y. Matsubara, J. P. Kraus, H. Ozasa et al., “Molecular cloning and nucleotide sequence of cDNA encoding the entire precursor of rat liver medium chain acyl coenzyme A dehydrogenase,” Journal of Biological Chemistry, vol. 262, no. 21, pp. 10104–10108, 1987. View at Google Scholar · View at Scopus
  12. J. J. Kim and R. Miura, “Acyl-CoA dehydrogenases and acyl-CoA oxidases: structural basis for mechanistic similarities and differences,” European Journal of Biochemistry, vol. 271, no. 3, pp. 483–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. T. G. Derks, M. Duran, H. R. Waterham, D. J. Reijngoud, L. P. Ten Kate, and G. P. A. Smit, “The difference between observed and expected prevalence of MCAD deficiency in the Netherlands: a genetic epidemiological study,” European Journal of Human Genetics, vol. 13, no. 8, pp. 947–952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. M. Maier, B. Liebl, W. Röschinger et al., “Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency,” Human Mutation, vol. 25, no. 5, pp. 443–452, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. J. Rhead, “Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective,” Journal of Inherited Metabolic Disease, vol. 29, no. 2-3, pp. 370–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Wilcken, M. Haas, P. Joy et al., “Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study,” The Lancet, vol. 369, no. 9555, pp. 37–42, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Coates, Y. D. chen, D. Curtis, N. Gregersen, D. kelly, and Y. Matsubara, “Molecular causing medium-chain acyl-CoA dehydrogenase deficiency: a collaborative compilation of the data fron 172 patients,” Progress in Clinical and Biological Research, vol. 375, pp. 499–506, 1992. View at Google Scholar
  18. N. Gregersen, P. Bross, and B. S. Andresen, “Genetic defects in fatty acid β-oxidation and acyl-CoA dehydrogenases: molecular pathogenesis and genotype-phenotype relationships,” European Journal of Biochemistry, vol. 271, no. 3, pp. 470–482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. S. Andresen, S. F. Dobrowolski, L. O'Reilly et al., “Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency,” The American Journal of Human Genetics, vol. 68, no. 6, pp. 1408–1418, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. B. S. Andresen, A. M. Lund, D. M. Hougaard et al., “MCAD deficiency in Denmark,” Molecular Genetics and Metabolism, vol. 106, pp. 175–188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Zschocke, A. Schulze, M. Lindner et al., “Molecular and functional characterisation of mild MCAD deficiency,” Human Genetics, vol. 108, no. 5, pp. 404–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Matsubara, K. Narisawa, S. Miyabayashi et al., “Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency,” Biochemical and Biophysical Research Communications, vol. 171, no. 1, pp. 498–505, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. J. T. McKinney, N. Longo, S. H. Hahn et al., “Rapid, comprehensive screening of the human medium chain acyl-CoA dehydrogenase gene,” Molecular Genetics and Metabolism, vol. 82, no. 2, pp. 112–120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Yokota, P. M. Coates, D. E. Hale, P. Rinaldo, and K. Tanaka, “Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency,” The American Journal of Human Genetics, vol. 49, no. 6, pp. 1280–1291, 1991. View at Google Scholar · View at Scopus
  25. G. La Marca, S. Malvagia, M. A. Donati, A. Morrone, E. Pasquini, and E. Zammarchi, “Rapid diagnosis of medium chain Acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 17, no. 23, pp. 2688–2692, 2003. View at Google Scholar · View at Scopus
  26. B. S. Andresen, P. Bross, S. Udvari et al., “The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?” Human Molecular Genetics, vol. 6, no. 5, pp. 695–707, 1997. View at Google Scholar · View at Scopus
  27. R. C. Edgar, “MUSCLE: multiple sequence alignment with high accuracy and high throughput,” Nucleic Acids Research, vol. 32, no. 5, pp. 1792–1797, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ashkenazy, E. Erez, E. Martz, T. Pupko, and N. Ben-Tal, “ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids,” Nucleic Acids Research, vol. 38, no. 2, pp. W529–W533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Li, V. G. Krishnan, M. E. Mort et al., “Automated inference of molecular mechanisms of disease from amino acid substitutions,” Bioinformatics, vol. 25, no. 21, pp. 2744–2750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Capriotti, P. Fariselli, and R. Casadio, “I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure,” Nucleic Acids Research, vol. 33, no. 2, pp. W306–W310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. H. J. K. Lee, M. Wang, R. Paschke, A. Nandy, S. Ghisla, and J. J. Kim, “Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity,” Biochemistry, vol. 35, no. 38, pp. 12412–12420, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Sobolev, A. Sorokine, J. Prilusky, E. E. Abola, and M. Edelman, “Automated analysis of interatomic contacts in proteins,” Bioinformatics, vol. 15, no. 4, pp. 327–332, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. G. F. Hoffmann, R. von Kries, D. Klose et al., “Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany,” European Journal of Pediatrics, vol. 163, no. 2, pp. 76–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Anderson, C. Botti, B. Li et al., “Medium chain acyl-CoA dehydrogenase deficiency detected among Hispanics by New Jersey newborn screening,” The American Journal of Medical Genetics A, vol. 158A, pp. 2100–2105, 2012. View at Google Scholar
  35. B. Liebl, U. Nennstiel-Ratzel, A. Roscher, and R. von Kries, “Data required for the evaluation of newborn screening programmes,” European Journal of Pediatrics, vol. 162, supplement 1, pp. S57–S61, 2003. View at Google Scholar · View at Scopus
  36. J. Oerton, J. M. Khalid, G. Besley et al., “Newborn screening for medium chain acyl-CoA ehydrogenase deficiency in England: prevalence, redictive value and test validity based on 1.5 million creened babies,” Journal of Medical Screening, vol. 18, no. 4, pp. 173–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Thodi, V. Georgiou, E. Molou et al., “Characterization of the molecular spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in a Greek newborns cohort: identification of a novel variant,” Clinical Biochemistry, vol. 45, pp. 1167–1172, 2012. View at Google Scholar
  38. D. M. Niu, Y. H. Chien, C. C. Chiang et al., “Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan,” Journal of Inherited Metabolic Disease, vol. 33, no. 2, pp. S295–S305, 2010. View at Google Scholar · View at Scopus
  39. S. Sander, N. Janzen, B. Janetzky et al., “Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany),” European Journal of Pediatrics, vol. 160, no. 5, pp. 318–319, 2001. View at Google Scholar · View at Scopus
  40. Y. Shigematsu, S. Hirano, I. Hata et al., “Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan,” Journal of Chromatography B, vol. 776, no. 1, pp. 39–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. A. K. Iafolla, R. J. Thompson Jr., and C. R. Roe, “Medium-chain acyl-coenzyme a dehydrogenase deficiency clinical course in 120 affected children,” Journal of Pediatrics, vol. 124, no. 3, pp. 409–415, 1994. View at Google Scholar · View at Scopus
  42. P. Rinaldo, H. R. Yoon, C. Yu, K. Raymond, C. Tiozzo, and G. Giordano, “Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders,” Seminars in Perinatology, vol. 23, no. 2, pp. 204–210, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Yokota, Y. Indo, P. M. Coates, and K. Tanaka, “Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation,” Journal of Clinical Investigation, vol. 86, no. 3, pp. 1000–1003, 1990. View at Google Scholar · View at Scopus
  44. C. M. Touw, G. P. Smit, M. de Vries et al., “Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study,” Orphanet Journal of Rare Diseases, vol. 7, p. 30, 2012. View at Google Scholar
  45. S. E. McCandless, R. Chandrasekar, S. Linard, S. Kikano, and L. Rice, “Sequencing from dried blood spots in infants with “false positive” newborn screen for MCAD deficiency,” Molecular Genetics and Metabolism, vol. 108, pp. 51–55, 2013. View at Google Scholar
  46. G. L. Arnold, C. A. Saavedra-Matiz, P. A. Galvin-Parton et al., “Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State,” Molecular Genetics and Metabolism, vol. 99, no. 3, pp. 263–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. E. M. Maier, J. Pongratz, A. C. Muntau et al., “Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening,” Clinical Genetics, vol. 76, no. 2, pp. 179–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Sturm, D. Herebian, M. Mueller, M. D. Laryea, and U. Spiekerkoetter, “Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants,” PLoS ONE, vol. 7, Article ID e45110, 2012. View at Google Scholar
  49. F. ter Veld, M. Mueller, S. Kramer et al., “A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns,” PLoS ONE, vol. 4, no. 7, Article ID e6449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Touw, G. P. Smit, K. E. Niezen-Koning et al., “In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes,” Orphanet Journal of Rare Diseases, vol. 8, no. 43, 2013. View at Publisher · View at Google Scholar
  51. E. M. Maier, S. W. Gersting, K. F. Kemter et al., “Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening,” Human Molecular Genetics, vol. 18, no. 9, pp. 1612–1623, 2009. View at Publisher · View at Google Scholar · View at Scopus